Let Flemingsberg Innovation Community elevate your idea
The Flemingsberg Innovation Community is a meeting place that brings together a range of organisations that provide various types of innovation support and assistance. Among them is Sting, which since its inception in 2002, has guided hundreds of startup companies to success.
“There are particularly good conditions for innovation to flourish from the research conducted at the academies in Flemingsberg and at Karolinska University Hospital,” says Pär Hedberg, CEO and founder of Sting.
“Projects in the area of challenge-driven innovation are especially interesting. This is where problems in care are identified that can be solved with the help of new ideas.”
Broad-based support is key
Hedberg highlights the Kraftcentrum Flemingsberg project that was previously run by Flemingsberg Science with the aim of developing new businesses from ideas and needs in healthcare.
“Flemingsberg also offers great potential for new businesses working in areas outside life science. For more people to succeed, they need to access the broad-based innovation support built up by Flemingsberg Science with extensive contact networks to more specialised innovation advisors,” says Hedberg.
The Flemingsberg Innovation Community brings together a number of organisations that provide help with patents, business ideas, financing, development, scaling up, collaboration with academia, society and business, co-working and networking.
Sign up for the distribution list for Flemingsberg Innovation Community and receive invitations to activities, events and meetings.
BioLamina Establishes Operations in Flemingsberg – A Key Player in ATMP Development
As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.
Sally Sow and Turn UP: Winners of the Flemingsberg Science Award IDEA 2024
The music world can be a challenging place, both for organizers trying to reach their audience and for music lovers searching for events that suit their taste. Sally Sow, the winner of the Flemingsberg Science Award IDEA 2024, has developed Turn Up, a platform that simplifies organizing, discovering, and participating in local music events. With a focus on inclusion and accessibility, she aims to create a music scene where everyone feels welcome.
KTH’s Technical Preparatory Year Moves to Flemingsberg – Student Numbers Expected to Double in Autumn 2025
In the autumn of 2025, KTH will relocate its Technical Preparatory Year spots from Södertälje to Flemingsberg, resulting in a significant increase in student numbers at Campus Flemingsberg. By nearly doubling available seats and introducing a new learning center model in collaboration with 3 municipalities, KTH aims to meet the growing demand for technical education in the region.
Drivhuset Stockholm – Where Future Entrepreneurs Take Their First Steps
Imagine a place where young ideas are free to grow, where passion meets ambition, and where the entrepreneurs of tomorrow take their first steps toward greatness. That’s exactly what Drivhuset Stockholm offers – a springboard for the next generation of entrepreneurs. Located on Campus Flemingsberg, we support students every day as they bring their ideas to life and build the skills needed to create real change. Our mission? To provide them with a safe, inspiring environment where they can test and develop their business ideas for real.
OptiCell Solutions – A Key Player in Cell and Gene Therapy Establishes in Flemingsberg
Flemingsberg continues to be a natural choice for knowledge-intensive and innovative businesses. OptiCell Solutions is a company that recently launched its operations at Novum Labs on Campus Flemingsberg. Founded in 2024 by specialists from Karolinska University Hospital and entrepreneurs from the Life Science industry, the company specializes in improving the availability of high-quality target cells for cell and gene therapies, a critical component of the growing ATMP (Advanced Therapy Medicinal Products) sector.
